Cargando…

Circulating Aminoterminal Propeptide of Type III Procollagen as a Biomarker of Cardiovascular Events in Patients Undergoing Hemodialysis

Aim: Type III collagen abundantly exists in the cardiovascular system, including the aorta and heart. We prospectively investigated whether serum levels of aminoterminal propeptide of type III procollagen (PIIINP), a circulating biomarker of cardiovascular fibrosis, could predict cardiovascular even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishimura, Masato, Tokoro, Toshiko, Takatani, Toru, Sato, Nodoka, Hashimoto, Tetsuya, Kobayashi, Hiroyuki, Ono, Toshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456459/ https://www.ncbi.nlm.nih.gov/pubmed/30111669 http://dx.doi.org/10.5551/jat.45138

Ejemplares similares

Effects of intravenous l-carnitine on myocardial fatty acid imaging in hemodialysis patients: responders or non-responders to l-carnitine
por: Nishimura, Masato, et al.
Publicado: (2015)

Value of Procollagen Type I Aminoterminal Propeptide in Women with Breast Cancer with regard to Metastases
por: Clouth, A., et al.
Publicado: (2011)

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.
por: Saarto, T., et al.
Publicado: (1998)

Association of Circulating Tissue Inhibitor of Metalloproteinases‐1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease
por: Lieb, Wolfgang, et al.
Publicado: (2019)

Idiopathic pre-capillary pulmonary hypertension in patients with end-stage kidney disease: effect of endothelin receptor antagonists
por: Nishimura, Masato, et al.
Publicado: (2016)

Relation of Procollagen Type III Amino Terminal Propeptide Level to Sepsis Severity in Pediatrics
por: Saleh, Nagwan Y., et al.
Publicado: (2021)

Quantitative Analysis of Serum Procollagen Type I C-Terminal Propeptide by Immunoassay on Microchip
por: Yatsushiro, Shouki, et al.
Publicado: (2011)

Procollagen C-proteinase Enhancer Stimulates Procollagen Processing by Binding to the C-propeptide Region Only
por: Vadon-Le Goff, Sandrine, et al.
Publicado: (2011)

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases
por: Gudowska, Monika, et al.
Publicado: (2017)

Visualized procollagen Iα1 demonstrates the intracellular processing of propeptides
por: Tanaka, Toshiaki, et al.
Publicado: (2022)

Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome
por: Ionin, Valery A., et al.
Publicado: (2020)

Focal impairment in myocardial fatty acid imaging in the left anterior descending artery area, a strong predictor for cardiac death in hemodialysis patients without obstructive coronary artery disease
por: Nishimura, Masato, et al.
Publicado: (2015)

Serum N‐Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism
por: Keyte, S.V., et al.
Publicado: (2016)

Procollagen type III amino‐terminal propeptide and insulin‐like growth factor I as biomarkers of growth hormone administration
por: Cowan, David A., et al.
Publicado: (2021)

Renal ultrasonographic shear-wave elastography and urinary procollagen type III amino-terminal propeptide in chronic kidney disease dogs
por: Thanaboonnipat, Chutimon, et al.
Publicado: (2020)

Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents
por: Choi, Ji Seon, et al.
Publicado: (2019)

Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells
Publicado: (1994)

Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease
por: Thanaboonnipat, Chutimon, et al.
Publicado: (2019)

Serum hyaluronic acid and procollagen III, N-terminal propeptide levels are highly associated with disease severity and predict the progression of COVID-19
por: Yang, Ti, et al.
Publicado: (2023)

Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification
por: Seo, Woo-Young, et al.
Publicado: (2017)

Intra-Individual Changes in Total Procollagen-Type 1 N-terminal Propeptide in a Korean Adult Population
por: Choi, Rihwa, et al.
Publicado: (2022)

Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults
por: Fragala, Maren S., et al.
Publicado: (2013)

The N-Terminal Propeptide of Type III Procollagen in Patients with Acute Coronary Syndrome: A Link between Left Ventricular End-Diastolic Pressure and Cardiovascular Events
por: Lee, Cheng-Hung, et al.
Publicado: (2015)

Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
por: Andersen, Thomas, et al.
Publicado: (2023)

Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease
por: Mosca, Antonella, et al.
Publicado: (2022)

Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
por: Veidal, Sanne Skovgård, et al.
Publicado: (2010)

Serum procollagen type 1 N propeptide: A novel diagnostic test for diabetic foot osteomyelitis – A case–control study
por: Hayes, Oliver G, et al.
Publicado: (2018)

Clinical significance of serum transforming growth factor-β1 and procollagen type I N-propeptide in post-tuberculosis tracheobronchial stenosis
por: Wu, Yongchang, et al.
Publicado: (2021)

Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide
Publicado: (1991)

Type IIA Procollagen Containing the Cysteine-rich Amino Propeptide Is Deposited in the Extracellular Matrix of Prechondrogenic Tissue and Binds to TGF-β1 and BMP-2
por: Zhu, Yong, et al.
Publicado: (1999)

Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction
por: Osokina, Anastasia, et al.
Publicado: (2021)

Circulating Procollagen Type III N-Terminal Peptide and Physical Function in the Long Life Family Study
por: Santanasto, Adam, et al.
Publicado: (2020)

Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery
por: De Simone, Matilde, et al.
Publicado: (2004)

Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation
por: Yamamoto, Takanori, et al.
Publicado: (2015)

Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
por: Shirakabe, Akihiro, et al.
Publicado: (2022)

Structural Basis for the Acceleration of Procollagen Processing by Procollagen C-Proteinase Enhancer-1
por: Pulido, David, et al.
Publicado: (2018)

Serum aminoterminal proctype natriuretic peptide in girls with idiopathic central precocious puberty during GNRHA treatment
por: Chen, Qiu-li, et al.
Publicado: (2013)

Effects of overinflation on procollagen type III expression in experimental acute lung injury
por: de Carvalho, Maria-Eudóxia Pilotto, et al.
Publicado: (2007)

Endoplasmic reticulum–to–Golgi trafficking of procollagen III via conventional vesicular and tubular carriers
por: Hirata, Yukihiro, et al.
Publicado: (2022)

Degradation-Suppressed Cocoonase for Investigating the Propeptide-Mediated Activation Mechanism
por: Sakata, Nana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tammhh3shpsm5svk7e7u6fecnp